Pacific Edge (PEB NZ)

Analysis

Health Care • New Zealand

Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.

Refresh

Company Presentation • 20 Aug 2026 10:00

AGM 2026

Company Presentation • 25 May 2026 07:00

H2 2026

Company Presentation • 26 Feb 2016 15:30

Investor presentation

Company Presentation • 16 Mar 2016 15:30

Investor presentation

Company Presentation • 10 Oct 2017 15:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00